TP53 and hepatocellular carcinoma: Hideaki et al. revealed that an array of six TAAs (p53, heat shock protein 70, HCC-22-5, peroxiredoxin VI, KM-HN-1, and p90) was capable of discriminating GC cases from HCs with sensitivity/specificity of 49.0/92.4% and 52.0/90.5% in test cohort and validation cohort (51).